Page 12 - Pink Sheet News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A federal appeals court issued a split decision on whether the abortion pill mifepristone should remain on the market — rejecting a lower court’s decision to effectively cancel the drug’s FDA approval in 2000, while ordering the rollback of more recent rules that made the drug easier to obtain. Nothing changes immediately, however, as the Supreme Court blocked the lower court’s ruling in the spring. It will be up to the high court to determine whether the pill remains available in the U.S. and under which conditions. Sarah Karlin-Smith of the Pink Sheet, Alice Miranda Ollstein of Polit...

A divided three-judge federal appeals court panel has ruled that a lower court was wrong to try to reverse entirely the FDA's approval of the abortion drug mifepristone.

A federal appeals court issued a split decision on whether the abortion pill mifepristone should remain on the market — rejecting a lower court’s decision to effectively cancel the drug’s FDA approval in 2000, while ordering the rollback of more recent rules that made the drug easier to obtain. Nothing changes immediately, however, as the Supreme Court blocked the lower court’s ruling in the spring. It will be up to the high court to determine whether the pill remains available in the U.S. and under which conditions. Sarah Karlin-Smith of the Pink Sheet, Alice Miranda Ollstein of Polit...

/PRNewswire/ -- Hiru Corporation would like to announce its financial performance for the 2nd Quarter ended June 30, 2023. For the three months ended June 30,...

A1 Group, Inc. - Co-Packing Agreement with Alkaline Water Company, ...